Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Michael Abrams, Ian MacLachlan

Premium

Tekmira Pharmaceuticals has appointed Michael Abrams as its chief discovery officer, in charge of drug-discovery efforts at the company.

Abrams previously served as vice president of research and development at CDRD Ventures, and before that was president and CEO of Inimex

Tekmira also said that it has named CSO Ian MacLachlan as executive vice president and chief technical officer in charge of medical countermeasures. In his new role, MacLachlan will handle the expansion of the company's pipeline.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.